Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 3
1965 2
1984 1
1985 2
1988 1
1989 1
1994 1
1997 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for ethoglucid[Title]
Your search for Etoglucid[Title] retrieved no results
Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone.
Kurth K, Tunn U, Ay R, Schröder FH, Pavone-Macaluso M, Debruyne F, ten Kate F, de Pauw M, Sylvester R. Kurth K, et al. J Urol. 1997 Aug;158(2):378-84. doi: 10.1016/s0022-5347(01)64484-7. J Urol. 1997. PMID: 9224307 Clinical Trial.
Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: preliminary results of a European organization for research on treatment of cancer. Randomized trial comparing doxorubicin hydrochloride, ethoglucid and transurethral resection alone.
Kurth KH, Schröder FH, Tunn U, Ay R, Pavone-Macaluso M, Debruyne F, de Pauw M, Dalesio O, ten Kate F. Kurth KH, et al. J Urol. 1984 Aug;132(2):258-62. doi: 10.1016/s0022-5347(17)49582-6. J Urol. 1984. PMID: 6376827 Clinical Trial.
Long-term follow-up in superficial transitional cell carcinoma of the bladder: prognostic factors for time to first recurrence, recurrence rate, and survival. Final results of a randomized trial comparing doxorubicin hydrochloride, ethoglucid, and transurethral resection alone. EORTC Genitourinary Tract Cancer Cooperative Group.
Kurth K, Schroeder FH, Debruyne F, Senge T, Pavone-Macaluso M, de Pauw M, ten Kate F, Sylvester R. Kurth K, et al. Prog Clin Biol Res. 1989;303:481-90. Prog Clin Biol Res. 1989. PMID: 2675005 Clinical Trial. No abstract available.
ETHOGLUCID IN TREATMENT OF INOPERABLE CEREBRAL TUMOURS.
BAILEY IC, TAYLOR AR, GREBBELL FS. BAILEY IC, et al. Br Med J. 1964 May 2;1(5391):1161-2. doi: 10.1136/bmj.1.5391.1161. Br Med J. 1964. PMID: 14120811 Free PMC article. No abstract available.
12 results